Skip to main content
Top
Published in: BMC Psychiatry 1/2010

Open Access 01-12-2010 | Research article

The Scandinavian Solutions for Wellness study - a two-arm observational study on the effectiveness of lifestyle intervention on subjective well-being and weight among persons with psychiatric disorders

Authors: Vibeke Porsdal, Catherine Beal, Ole Kristian Kleivenes, Egil W Martinsen, Eva Lindström, Harriet Nilsson, Pär Svanborg

Published in: BMC Psychiatry | Issue 1/2010

Login to get access

Abstract

Background

Solutions for Wellness (SfW) is an educational 3-month program concerning nutrition and exercise for persons with psychiatric disorders on psychotropic medication, who have weight problems. This observational study assessed the impact of SfW on subjective well-being, weight and waist circumference (WC).

Methods

Data was collected at 49 psychiatric clinics. Where the SfW program was offered patients could enter the intervention group; where not, the control group. Subjective well-being was measured by the Subjective Well-being under Neuroleptics scale (SWN), at baseline, at the end of SfW participation, and at a follow-up 6 months after baseline. Demographic, disease and treatment data was also collected.

Results

314 patients enrolled in the SfW group, 59 in the control group. 54% of the patients had schizophrenia, 67% received atypical antipsychotics, 56% were female. They averaged 41 ± 12.06 years and had a BMI of 31.4 ± 6.35. There were significant differences at baseline between groups for weight, SWN total score and other factors. Stepwise logistic models controlling for baseline covariates yielded an adjusted non-significant association between SfW program participation and response in subjective well-being (SWN increase). However, statistically significant associations were found between program participation and weight-response (weight loss or gain < 1 kg) OR = 2; 95% CI [1.1; 3.7] and between program participation and WC-response (WC decrease or increase < 2 cm) OR = 5; 95% CI [2.4; 10.3]), at 3 months after baseline.

Conclusions

SfW program participation was associated with maintaining or decreasing weight and WC but not with improved subjective well-being as measured with the SWN scale.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organ Tech Rep Ser: Obesity: preventing and managing the global epidemic. Report of a WHO consultation. 2000, 894: i-xii. 1-253 World Health Organ Tech Rep Ser: Obesity: preventing and managing the global epidemic. Report of a WHO consultation. 2000, 894: i-xii. 1-253
2.
go back to reference Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, Degraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL: Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006, 37: 1583-633.CrossRefPubMed Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, Degraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL: Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006, 37: 1583-633.CrossRefPubMed
3.
go back to reference Kawachi I: Physical and psychological consequences of weight gain. J Clin Psychiatry. 1999, 60: 5-9. 10.4088/JCP.v60n0102.CrossRefPubMed Kawachi I: Physical and psychological consequences of weight gain. J Clin Psychiatry. 1999, 60: 5-9. 10.4088/JCP.v60n0102.CrossRefPubMed
4.
go back to reference Holt RIG, Peveler RC: Obesity, serious mental illness and antipsychotic drugs. Diabetes Obes Metab. 2009, 11: 665-79. 10.1111/j.1463-1326.2009.01038.x.CrossRefPubMed Holt RIG, Peveler RC: Obesity, serious mental illness and antipsychotic drugs. Diabetes Obes Metab. 2009, 11: 665-79. 10.1111/j.1463-1326.2009.01038.x.CrossRefPubMed
5.
go back to reference Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK: Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents. JAMA. 2009, 302: 1765-1773. 10.1001/jama.2009.1549.CrossRefPubMedPubMedCentral Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK: Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents. JAMA. 2009, 302: 1765-1773. 10.1001/jama.2009.1549.CrossRefPubMedPubMedCentral
6.
go back to reference Nasrallah H: A review of the effect of atypical antipsychotics on weight. Psychoneuroendocrinology. 2003, 28: 83-96. 10.1016/S0306-4530(02)00114-2.CrossRefPubMed Nasrallah H: A review of the effect of atypical antipsychotics on weight. Psychoneuroendocrinology. 2003, 28: 83-96. 10.1016/S0306-4530(02)00114-2.CrossRefPubMed
7.
go back to reference Garland EJ, Remick RA, Zis AP: Weight gain with antidepressants and lithium. J Clin Psychopharmacol. 1988, 8: 323-30. 10.1097/00004714-198810000-00003.CrossRefPubMed Garland EJ, Remick RA, Zis AP: Weight gain with antidepressants and lithium. J Clin Psychopharmacol. 1988, 8: 323-30. 10.1097/00004714-198810000-00003.CrossRefPubMed
8.
go back to reference Pijl H, Meinders AE: Bodyweight change as an adverse effect of drug treatment. Mechanisms and management. Drug Saf. 1996, 14: 329-42. 10.2165/00002018-199614050-00005.CrossRefPubMed Pijl H, Meinders AE: Bodyweight change as an adverse effect of drug treatment. Mechanisms and management. Drug Saf. 1996, 14: 329-42. 10.2165/00002018-199614050-00005.CrossRefPubMed
9.
go back to reference Chen CK, Chen YC, Huang YS: Effects of a 10-week weight control program on obese patients with schizophrenia or schizoaffective disorder: a 12-month follow up. Psychiatry Clin Neurosci. 2009, 63: 17-22. 10.1111/j.1440-1819.2008.01886.x.CrossRefPubMed Chen CK, Chen YC, Huang YS: Effects of a 10-week weight control program on obese patients with schizophrenia or schizoaffective disorder: a 12-month follow up. Psychiatry Clin Neurosci. 2009, 63: 17-22. 10.1111/j.1440-1819.2008.01886.x.CrossRefPubMed
10.
go back to reference Kwon JS, Choi JS, Bahk WM, Yoon Kim C, Hyung Kim C, Chul Shin Y, Park BJ, Geun Oh C: Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: A 12-week randomized controlled clinical trial. J Clin Psychiatry. 2006, 67: 547-553. 10.4088/JCP.v67n0405.CrossRefPubMed Kwon JS, Choi JS, Bahk WM, Yoon Kim C, Hyung Kim C, Chul Shin Y, Park BJ, Geun Oh C: Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: A 12-week randomized controlled clinical trial. J Clin Psychiatry. 2006, 67: 547-553. 10.4088/JCP.v67n0405.CrossRefPubMed
11.
go back to reference Pendlebury J, Bushe CJ, Wildgust HJ, Holt RI: Long-term maintenance of weight loss in patients with severe mental illness through a behavioural treatment programme in the UK. Acta Psychiatr Scand. 2007, 115: 286-94. 10.1111/j.1600-0447.2006.00906.x.CrossRefPubMed Pendlebury J, Bushe CJ, Wildgust HJ, Holt RI: Long-term maintenance of weight loss in patients with severe mental illness through a behavioural treatment programme in the UK. Acta Psychiatr Scand. 2007, 115: 286-94. 10.1111/j.1600-0447.2006.00906.x.CrossRefPubMed
12.
go back to reference Lee SJ, Choi EJ, Kwon JS: A naturalistic multicenter trial of a 12-week weight management program for overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry. 2008, 69: 555-62. 10.4088/JCP.v69n0406.CrossRefPubMed Lee SJ, Choi EJ, Kwon JS: A naturalistic multicenter trial of a 12-week weight management program for overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry. 2008, 69: 555-62. 10.4088/JCP.v69n0406.CrossRefPubMed
13.
go back to reference Vreeland B, Minsky S, Menza M, Rigassio Radler D, Roemheld-Hamm B, Stern R: A program for managing weight gain associated with atypical antipsychotics. Psychiatr Serv. 2003, 54: 1155-7. 10.1176/appi.ps.54.8.1155.CrossRefPubMed Vreeland B, Minsky S, Menza M, Rigassio Radler D, Roemheld-Hamm B, Stern R: A program for managing weight gain associated with atypical antipsychotics. Psychiatr Serv. 2003, 54: 1155-7. 10.1176/appi.ps.54.8.1155.CrossRefPubMed
14.
go back to reference Hoffmann VP, Ahl J, Meyers A, Schuh L, Shults KS, Collins DM, Jensen L: Wellness intervention for patients with serious and persistent mental illness. J Clin Psychiatry. 2005, 66: 1576-79. 10.4088/JCP.v66n1213.CrossRefPubMed Hoffmann VP, Ahl J, Meyers A, Schuh L, Shults KS, Collins DM, Jensen L: Wellness intervention for patients with serious and persistent mental illness. J Clin Psychiatry. 2005, 66: 1576-79. 10.4088/JCP.v66n1213.CrossRefPubMed
15.
go back to reference Bushe CJ, McNamara D, Haley C, McCrossan MF, Devitt P: Weight management in a cohort of Irish inpatients with serious mental illness (SMI) using a modular behavioural programme. A preliminary service evaluation. BMC Psychiatry. 2008, 8: 76-10.1186/1471-244X-8-76.CrossRefPubMedPubMedCentral Bushe CJ, McNamara D, Haley C, McCrossan MF, Devitt P: Weight management in a cohort of Irish inpatients with serious mental illness (SMI) using a modular behavioural programme. A preliminary service evaluation. BMC Psychiatry. 2008, 8: 76-10.1186/1471-244X-8-76.CrossRefPubMedPubMedCentral
16.
go back to reference Menza M, Vreeland B, Minsky S, Gara M, Radler DR, Sakowitz M: Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program. J Clin Psychiatry. 2004, 65: 471-7. 10.4088/JCP.v65n0404.CrossRefPubMed Menza M, Vreeland B, Minsky S, Gara M, Radler DR, Sakowitz M: Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program. J Clin Psychiatry. 2004, 65: 471-7. 10.4088/JCP.v65n0404.CrossRefPubMed
17.
go back to reference Poulin MJ, Chaput JP, Simard V, Vincent P, Bernier J, Gauthier Y, Lanctôt G, Saindon J, Vincent A, Gagnon S, Tremblay A: Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme. Aust N Z J Psychiatry. 2007, 41: 980-9. 10.1080/00048670701689428.CrossRefPubMed Poulin MJ, Chaput JP, Simard V, Vincent P, Bernier J, Gauthier Y, Lanctôt G, Saindon J, Vincent A, Gagnon S, Tremblay A: Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme. Aust N Z J Psychiatry. 2007, 41: 980-9. 10.1080/00048670701689428.CrossRefPubMed
18.
go back to reference Evans S, Newton R, Higgins S: Nutritional intervention to prevent weight gain in patients commenced on olanzapine: a randomized controlled trial. Aust N Z J Psychiatry. 2005, 39: 479-86.PubMed Evans S, Newton R, Higgins S: Nutritional intervention to prevent weight gain in patients commenced on olanzapine: a randomized controlled trial. Aust N Z J Psychiatry. 2005, 39: 479-86.PubMed
19.
go back to reference Alvarez-Jiménez M, González-Blanch C, Vázquez-Barquero JL, Pérez-Iglesias R, Martínez-García O, Pérez-Pardal T, Ramírez-Bonilla ML, Crespo-Facorro B: Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: A randomized controlled trial. J Clin Psychiatry. 2006, 67: 1253-60. 10.4088/JCP.v67n0812.CrossRefPubMed Alvarez-Jiménez M, González-Blanch C, Vázquez-Barquero JL, Pérez-Iglesias R, Martínez-García O, Pérez-Pardal T, Ramírez-Bonilla ML, Crespo-Facorro B: Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: A randomized controlled trial. J Clin Psychiatry. 2006, 67: 1253-60. 10.4088/JCP.v67n0812.CrossRefPubMed
20.
go back to reference Khazaal Y, Fresard E, Rabia S, Chatton A, Rothen S, Pomini V, Grasset F, Borgeat F, Zullino D: Cognitive behavioural therapy for weight gain associated with antipsychotic drugs. Schizophr Res. 2007, 91: 169-77. 10.1016/j.schres.2006.12.025.CrossRefPubMed Khazaal Y, Fresard E, Rabia S, Chatton A, Rothen S, Pomini V, Grasset F, Borgeat F, Zullino D: Cognitive behavioural therapy for weight gain associated with antipsychotic drugs. Schizophr Res. 2007, 91: 169-77. 10.1016/j.schres.2006.12.025.CrossRefPubMed
21.
go back to reference Littrell KH, Hilligoss NM, Kirshner CD, Petty RG, Johnson CG: The effects of an educational intervention on antipsychotic-induced weight gain. J Nur Scholarsh. 2003, 35: 237-41. 10.1111/j.1547-5069.2003.00237.x.CrossRef Littrell KH, Hilligoss NM, Kirshner CD, Petty RG, Johnson CG: The effects of an educational intervention on antipsychotic-induced weight gain. J Nur Scholarsh. 2003, 35: 237-41. 10.1111/j.1547-5069.2003.00237.x.CrossRef
22.
go back to reference Brar JS, Ganguli R, Pandina G, Turkoz I, Berry S, Mahmoud R: Effects of ehavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry. 2005, 66: 205-12. 10.4088/JCP.v66n0208.CrossRefPubMed Brar JS, Ganguli R, Pandina G, Turkoz I, Berry S, Mahmoud R: Effects of ehavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry. 2005, 66: 205-12. 10.4088/JCP.v66n0208.CrossRefPubMed
23.
go back to reference Smith S, Yeomans D, Bushe CJ, Eriksson C, Harrison T, Holmes R, Mynors-Wallis L, Oatway H, Sullivan G: A well-being programme in severe mental illness. Reducing risk for physical ill-health: A post-programme service evaluation at 2 years. Eur Psychiatry. 2007, 22: 413-8. 10.1016/j.eurpsy.2007.07.002.CrossRefPubMed Smith S, Yeomans D, Bushe CJ, Eriksson C, Harrison T, Holmes R, Mynors-Wallis L, Oatway H, Sullivan G: A well-being programme in severe mental illness. Reducing risk for physical ill-health: A post-programme service evaluation at 2 years. Eur Psychiatry. 2007, 22: 413-8. 10.1016/j.eurpsy.2007.07.002.CrossRefPubMed
24.
go back to reference Mauri M, Simoncini M, Castrogiovanni S, Iovieno N, Cecconi D, Dell'Agnello G, Quadrigli M, Rossi A, Donda P, Fagiolini A, Cassano GB: A psychoeducational program for weight loss in patients who have experienced weight gain during antipsychotic treatment with olanzapine. Pharmacotherapy. 2008, 41: 17-23. Mauri M, Simoncini M, Castrogiovanni S, Iovieno N, Cecconi D, Dell'Agnello G, Quadrigli M, Rossi A, Donda P, Fagiolini A, Cassano GB: A psychoeducational program for weight loss in patients who have experienced weight gain during antipsychotic treatment with olanzapine. Pharmacotherapy. 2008, 41: 17-23.
25.
go back to reference Gabriele JM, Dubbert PM, Reeves RR: Efficacy of behavioural interventions in managing atypical antipsychotic weight gain. Obesity. 2009, 10: 442-455. 10.1111/j.1467-789X.2009.00570.x.CrossRef Gabriele JM, Dubbert PM, Reeves RR: Efficacy of behavioural interventions in managing atypical antipsychotic weight gain. Obesity. 2009, 10: 442-455. 10.1111/j.1467-789X.2009.00570.x.CrossRef
26.
go back to reference Ganguli R: Behavioral Therapy for Weight Loss in Patients With Schizophrenia. J Clin Psychiatry. 2007, 68: 19-25. 10.4088/JCP.0607e14.CrossRefPubMed Ganguli R: Behavioral Therapy for Weight Loss in Patients With Schizophrenia. J Clin Psychiatry. 2007, 68: 19-25. 10.4088/JCP.0607e14.CrossRefPubMed
27.
go back to reference Alvarez-Jiménez M, Hetrick SE, González-Blanch C, Gleeson JF, McGorry PD: Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials. Br J Psychiatry. 2008, 193: 101-107. 10.1192/bjp.bp.107.042853.CrossRefPubMed Alvarez-Jiménez M, Hetrick SE, González-Blanch C, Gleeson JF, McGorry PD: Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials. Br J Psychiatry. 2008, 193: 101-107. 10.1192/bjp.bp.107.042853.CrossRefPubMed
28.
go back to reference Faulkner G, Cohn T, Remington G: Interventions to reduce weight gain in schizophrenia. Cochrane Database of Systematic Reviews. 2007, 24: CD005148- Faulkner G, Cohn T, Remington G: Interventions to reduce weight gain in schizophrenia. Cochrane Database of Systematic Reviews. 2007, 24: CD005148-
29.
go back to reference Naber D: A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. Int Clin Psychopharmacol. 1995, 10: 133-138.PubMed Naber D: A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. Int Clin Psychopharmacol. 1995, 10: 133-138.PubMed
30.
go back to reference Naber D, Moritz S, Lambert M, Pajonk FG, Holzbach R, Mass R, Andresen B: Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs. Schizophr Res. 2001, 50: 79-88. 10.1016/S0920-9964(00)00166-3.CrossRefPubMed Naber D, Moritz S, Lambert M, Pajonk FG, Holzbach R, Mass R, Andresen B: Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs. Schizophr Res. 2001, 50: 79-88. 10.1016/S0920-9964(00)00166-3.CrossRefPubMed
31.
go back to reference Sintonen H: The 15D instrument of health-related quality of life: properties and applications. Ann Med. 2001, 33: 328-36. 10.3109/07853890109002086.CrossRefPubMed Sintonen H: The 15D instrument of health-related quality of life: properties and applications. Ann Med. 2001, 33: 328-36. 10.3109/07853890109002086.CrossRefPubMed
32.
go back to reference Guy W: Clinical Global Impression (CGI). Handbook of psychiatric measures. Edited by: Rush AJ. 2000, American Psychiatric Association, Washington, DC, 100-102. Guy W: Clinical Global Impression (CGI). Handbook of psychiatric measures. Edited by: Rush AJ. 2000, American Psychiatric Association, Washington, DC, 100-102.
33.
go back to reference Naber D, Walther A, Kircher T, Hayek D, Holzbach R: Subjective effects of neuroleptics predict compliance. Prediction of neuroleptic treatment outcome in schizophrenia. Concepts and methods. Edited by: Gaebel W, Awad R. 1994, Springer, Heidelberg, 85-98.CrossRef Naber D, Walther A, Kircher T, Hayek D, Holzbach R: Subjective effects of neuroleptics predict compliance. Prediction of neuroleptic treatment outcome in schizophrenia. Concepts and methods. Edited by: Gaebel W, Awad R. 1994, Springer, Heidelberg, 85-98.CrossRef
34.
go back to reference Naber D, Riedel M, Klimke A, Vorbach EU, Lambert M, Kühn KU, Bender S, Bandelow B, Lemmer W, Moritz S, Dittmann RW: Randomized double blind comparison of olanzapine vs.. clozapine on subjective well-being and clinical outcome in patients with schizophrenia. Acta Psychiatr Scand. 2005, 111: 106-15. 10.1111/j.1600-0447.2004.00486.x.CrossRefPubMed Naber D, Riedel M, Klimke A, Vorbach EU, Lambert M, Kühn KU, Bender S, Bandelow B, Lemmer W, Moritz S, Dittmann RW: Randomized double blind comparison of olanzapine vs.. clozapine on subjective well-being and clinical outcome in patients with schizophrenia. Acta Psychiatr Scand. 2005, 111: 106-15. 10.1111/j.1600-0447.2004.00486.x.CrossRefPubMed
35.
go back to reference de Haan L, Weisfelt M, Dingemans PM, Linszen DH, Wouters L: Psychometric properties of the Subjective Well-Being Under Neuroleptics scale and the Subjective Deficit Syndrome Scale. Psychopharmacol (Berl). 2002, 162: 24-28. 10.1007/s00213-002-1054-x.CrossRef de Haan L, Weisfelt M, Dingemans PM, Linszen DH, Wouters L: Psychometric properties of the Subjective Well-Being Under Neuroleptics scale and the Subjective Deficit Syndrome Scale. Psychopharmacol (Berl). 2002, 162: 24-28. 10.1007/s00213-002-1054-x.CrossRef
Metadata
Title
The Scandinavian Solutions for Wellness study - a two-arm observational study on the effectiveness of lifestyle intervention on subjective well-being and weight among persons with psychiatric disorders
Authors
Vibeke Porsdal
Catherine Beal
Ole Kristian Kleivenes
Egil W Martinsen
Eva Lindström
Harriet Nilsson
Pär Svanborg
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2010
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/1471-244X-10-42

Other articles of this Issue 1/2010

BMC Psychiatry 1/2010 Go to the issue